These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7533735

  • 1. Nitric oxide synthesis and the effect of aminoguanidine and NG-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat.
    Wu G.
    Diabetes; 1995 Mar; 44(3):360-4. PubMed ID: 7533735
    [Abstract] [Full Text] [Related]

  • 2. N omega-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats.
    Lindsay RM, Smith W, Rossiter SP, McIntyre MA, Williams BC, Baird JD.
    Diabetes; 1995 Mar; 44(3):365-8. PubMed ID: 7533736
    [Abstract] [Full Text] [Related]

  • 3. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.
    Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gilkeson GS.
    J Exp Med; 1994 Feb 01; 179(2):651-60. PubMed ID: 7507509
    [Abstract] [Full Text] [Related]

  • 4. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
    Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML.
    Diabetes; 1992 Apr 01; 41(4):552-6. PubMed ID: 1376704
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of nitric oxide formation by guanidines.
    Hasan K, Heesen BJ, Corbett JA, McDaniel ML, Chang K, Allison W, Wolffenbuttel BH, Williamson JR, Tilton RG.
    Eur J Pharmacol; 1993 Nov 02; 249(1):101-6. PubMed ID: 7506664
    [Abstract] [Full Text] [Related]

  • 6. The activation of the arginine-citrulline cycle in macrophages from the spontaneously diabetic BB rat.
    Wu G, Flynn NE.
    Biochem J; 1993 Aug 15; 294 ( Pt 1)(Pt 1):113-8. PubMed ID: 8363561
    [Abstract] [Full Text] [Related]

  • 7. Effects of guanidino and uremic compounds on nitric oxide pathways.
    MacAllister RJ, Whitley GS, Vallance P.
    Kidney Int; 1994 Mar 15; 45(3):737-42. PubMed ID: 7515129
    [Abstract] [Full Text] [Related]

  • 8. Effects of inhibition of nitric oxide synthesis on TNF alpha serum levels in E. coli endotoxemic rats.
    Boczkowski J, Philip I, Tedgui A, Bernard C, Merval R, Desmonts JM, Aubier M.
    Life Sci; 1995 Mar 15; 57(13):PL147-52. PubMed ID: 7545771
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD, Paisley K, Martin W.
    Br J Pharmacol; 1993 Nov 15; 110(3):1003-8. PubMed ID: 7507774
    [Abstract] [Full Text] [Related]

  • 10. Aminoguanidine selectively inhibits inducible nitric oxide synthase.
    Griffiths MJ, Messent M, MacAllister RJ, Evans TW.
    Br J Pharmacol; 1993 Nov 15; 110(3):963-8. PubMed ID: 7507781
    [Abstract] [Full Text] [Related]

  • 11. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
    Lindsay RM, Peet RS, Wilkie GS, Rossiter SP, Smith W, Baird JD, Williams BC.
    Br J Pharmacol; 1997 Jan 15; 120(1):1-6. PubMed ID: 9117082
    [Abstract] [Full Text] [Related]

  • 12. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo.
    Laszlo F, Evans SM, Whittle BJ.
    Eur J Pharmacol; 1995 Jan 16; 272(2-3):169-75. PubMed ID: 7536162
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide in streptozotocin-induced diabetes mellitus in rats.
    Maree A, Peer G, Iaina A, Blum M, Wollman Y, Csernihovsky T, Silverberg DS, Cabili S.
    Clin Sci (Lond); 1996 May 16; 90(5):379-84. PubMed ID: 8665775
    [Abstract] [Full Text] [Related]

  • 14. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
    Joly GA, Ayres M, Chelly F, Kilbourn RG.
    Biochem Biophys Res Commun; 1994 Feb 28; 199(1):147-54. PubMed ID: 7510104
    [Abstract] [Full Text] [Related]

  • 15. N omega -monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection.
    Bastian NR, Xu S, Shao XL, Shelby J, Granger DL, Hibbs JB.
    Biochim Biophys Acta; 1994 May 25; 1226(2):225-31. PubMed ID: 7515690
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide-inhibitory effect of aminoguanidine on renal function in rats.
    Waz WR, Van Liew JB, Feld LG.
    Kidney Blood Press Res; 1997 May 25; 20(4):211-7. PubMed ID: 9398025
    [Abstract] [Full Text] [Related]

  • 17. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival.
    Winlaw DS, Schyvens CG, Smythe GA, Du ZY, Rainer SP, Lord RS, Spratt PM, Macdonald PS.
    Transplantation; 1995 Jul 15; 60(1):77-82. PubMed ID: 7624947
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide produced during murine listeriosis is protective.
    Boockvar KS, Granger DL, Poston RM, Maybodi M, Washington MK, Hibbs JB, Kurlander RL.
    Infect Immun; 1994 Mar 15; 62(3):1089-100. PubMed ID: 7509315
    [Abstract] [Full Text] [Related]

  • 19. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis.
    Zielasek J, Jung S, Gold R, Liew FY, Toyka KV, Hartung HP.
    J Neuroimmunol; 1995 Apr 15; 58(1):81-8. PubMed ID: 7537283
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide synthase inhibition reduces wakefulness.
    Dzoljic MR, De Vries R.
    Neuropharmacology; 1994 Nov 15; 33(11):1505-9. PubMed ID: 7532835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.